RESUMEN
OBJECTIVES: We determined the interactions between efficacy of antibiotic treatment, pathogen growth rates and between-organ spread during systemic Salmonella infections. METHODS: We infected mice with isogenic molecularly tagged subpopulations of either a fast-growing WT or a slow-growing ΔaroC Salmonella strain. We monitored viable bacterial numbers and fluctuations in the proportions of each bacterial subpopulation in spleen, liver, blood and mesenteric lymph nodes (MLNs) before, during and after the cessation of treatment with ampicillin and ciprofloxacin. RESULTS: Both antimicrobials induced a reduction in viable bacterial numbers in the spleen, liver and blood. This reduction was biphasic in infections with fast-growing bacteria, with a rapid initial reduction followed by a phase of lower effect. Conversely, a slow and gradual reduction of the bacterial load was seen in infections with the slow-growing strain, indicating a positive correlation between bacterial net growth rates and the efficacy of ampicillin and ciprofloxacin. The viable numbers of either bacterial strain remained constant in MLNs throughout the treatment with a relapse of the infection with WT bacteria occurring after cessation of the treatment. The frequency of each tagged bacterial subpopulation was similar in the spleen and liver, but different from that of the MLNs before, during and after treatment. CONCLUSIONS: In Salmonella infections, bacterial growth rates correlate with treatment efficacy. MLNs are a site with a bacterial population structure different to those of the spleen and liver and where the total viable bacterial load remains largely unaffected by antimicrobials, but can resume growth after cessation of treatment.
Asunto(s)
Ampicilina/administración & dosificación , Antibacterianos/administración & dosificación , Carga Bacteriana , Ciprofloxacina/administración & dosificación , Infecciones por Salmonella/microbiología , Salmonella/aislamiento & purificación , Sepsis/microbiología , Estructuras Animales/microbiología , Animales , Sangre/microbiología , Modelos Animales de Enfermedad , Femenino , Ratones Endogámicos C57BL , Salmonella/efectos de los fármacos , Infecciones por Salmonella/tratamiento farmacológico , Sepsis/tratamiento farmacológico , Análisis Espacio-TemporalRESUMEN
In Salmonella enterica serovar Typhimurium, trxA encodes thioredoxin 1, a small, soluble protein with disulfide reductase activity, which catalyzes thiol disulfide redox reactions in a variety of substrate proteins. Thioredoxins are involved as antioxidants in defense against oxidative stresses, such as exposure to hydrogen peroxide and hydroxyl radicals. We have made a defined, complete deletion of trxA in the mouse-virulent S. Typhimurium strain SL1344 (SL1344 trxA), replacing the gene with a kanamycin resistance gene cassette. SL1344 trxA was attenuated for virulence in BALB/c mice by the oral and intravenous routes and when used in immunization experiments provided protection against challenge with the virulent parent strain. SL1344 trxA induced less inflammation in murine spleens and livers than SL3261, the aroA mutant, live attenuated vaccine strain. The reduced splenomegaly observed following infection with SL1344 trxA was partially attributed to a reduction in the number of both CD4(+) and CD8(+) T cells and B lymphocytes in the spleen and reduced infiltration by CD11b(+) cells into the spleen compared with spleens from mice infected with SL3261. This less severe pathological response indicates that a trxA mutation might be used to reduce reactogenicity of live attenuated vaccine strains. We tested this by deleting trxA in SL3261. SL3261 trxA was also less inflammatory than SL3261 but was slightly less effective as a vaccine strain than either the SL3261 parent strain or SL1344 trxA.
Asunto(s)
Proteínas Bacterianas/inmunología , Proteínas Bacterianas/metabolismo , Inflamación/inducido químicamente , Salmonelosis Animal/prevención & control , Vacunas contra la Salmonella/inmunología , Salmonella typhimurium/metabolismo , Animales , Proteínas Bacterianas/genética , Inyecciones Intravenosas , Lipopolisacáridos , Hígado/patología , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Mutación , Salmonelosis Animal/patología , Vacunas contra la Salmonella/administración & dosificación , Vacunas contra la Salmonella/efectos adversos , Salmonella typhimurium/genética , Salmonella typhimurium/inmunología , Bazo/patología , Factores de Tiempo , Receptor Toll-Like 4/genética , VirulenciaRESUMEN
To assess the role of the glycolytic enzyme phosphofructokinase (Pfk) in the in vivo fitness of the pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) we have generated single and double gene deletion mutants of the two known isoforms of this enzyme, pfkA and pfkB. In a mouse model of typhoid fever, bacterial counts in the spleen and liver were similar between wild type and single pfkA and pfkB mutant-infected mice. However, a double pfkAB mutant was significantly attenuated for growth in vivo. This defect was complemented by provision of either pfkA or pfkB on pBR322. Together these data show that Pfk activity is required for the full in vivo fitness of S. Typhimurium with functional redundancy between pfkA and pfkB. The level of attenuation of the pfkAB double mutant was not sufficient for its consideration as a live attenuated vaccine strain.
Asunto(s)
Proteínas Bacterianas/metabolismo , Fosfofructoquinasa-1/metabolismo , Fosfofructoquinasa-2/metabolismo , Salmonella typhimurium/enzimología , Salmonella typhimurium/crecimiento & desarrollo , Fiebre Tifoidea/microbiología , Animales , Proteínas Bacterianas/genética , Femenino , Humanos , Hígado/microbiología , Ratones , Ratones Endogámicos BALB C , Fosfofructoquinasa-1/genética , Fosfofructoquinasa-2/genética , Salmonella typhimurium/genética , Eliminación de Secuencia , Bazo/microbiologíaRESUMEN
Sepsis and endotoxaemia are important causes of morbidity and mortality in humans. Research on sepsis focuses on rodent models most of which are poorly responsive to lipopolysaccharide (LPS), and thus do not mimic very well the high sensitivity of humans. Therefore, there is a need to develop more clinically relevant models. Horses suffer from a similar endotoxaemic syndrome to humans with high morbidity and mortality. LPS analogues that act as antagonists at Toll-like receptor 4 (TLR4) are being developed as novel treatments for endotoxaemia. Due to differences in recognition of ligands by TLR4 from different mammalian species, individual LPS molecules may act as agonists in some species and antagonists in others. The synthetic lipid A analogue E5531 is an antagonist at TLR4 in humans and mice, but its effects at TLR4 from other species are unknown. In the studies reported here, Escherichia coli LPS is a full agonist on equine bone marrow macrophage-like cells and its effects are antagonised by E5531. Similarly, E. coli LPS is an agonist and E5531 an antagonist on monocytes isolated from peripheral blood of healthy horses and human embryonic kidney (HEK) cells, transiently transfected to express horse TLR4 and its associated cell surface proteins MD2 and CD14. In contrast, both E. coli LPS and E5531 behave as agonists in horse whole blood by inducing production of equivalent amounts of the inflammatory mediator prostaglandin. This finding suggests that modification of E5531 may occur in whole blood, for example, deacylation, which alters its activity. This comparative study has revealed a novel pharmacological action of E5531 and emphasises the importance of extending studies of this nature beyond the normal rodent models.
Asunto(s)
Lípido A/análogos & derivados , Receptor Toll-Like 4/agonistas , Receptor Toll-Like 4/antagonistas & inhibidores , Animales , Línea Celular , Dinoprostona/sangre , Modelos Animales de Enfermedad , Endotoxemia/etiología , Epoprostenol/sangre , Femenino , Humanos , Técnicas In Vitro , Interferón gamma/farmacología , Lípido A/farmacología , Lipopolisacáridos/farmacología , Masculino , Ratones , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Proteínas Recombinantes/agonistas , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/genética , Sepsis/etiología , Especificidad de la Especie , Receptor Toll-Like 4/sangre , Receptor Toll-Like 4/genética , TransfecciónRESUMEN
In this study, we report the entire nucleotide sequence of an aroA homologue encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), isolated from the cyanobacterium Synechocystis sp. PCC 6803. The proposed coding region is an open reading frame of 447 amino acids. The deduced sequence of the gene product is particularly similar to the Gram+ EPSPS sequences available to date, in particular to that in Bacillus subtilis. Analysis of the Synechocystis putative EPSPS sequence does not lead to an obvious explanation for the natural tolerance of this cyanobacterium to glyphosate.
Asunto(s)
Transferasas Alquil y Aril , Cianobacterias/enzimología , Transferasas/genética , 3-Fosfoshikimato 1-Carboxiviniltransferasa , Secuencia de Aminoácidos , Secuencia de Bases , Cianobacterias/genética , ADN Bacteriano , Genes Bacterianos , Datos de Secuencia Molecular , Transferasas/químicaRESUMEN
Lipopolysaccharide (LPS) structures on Haemophilus influenzae, defined by monoclonal antibodies, can show phase variation from generation to generation. Several genetic loci are involved in LPS biosynthesis by H. influenzae. In this paper, we describe three loci which play a role in LPS phase variation: the lic loci; lic1 and lic3 have been sequenced and lic2 has been partially sequenced. Each locus consists of multiple open reading frames (ORF), and each contains a repetitive sequence within the 5' end of the first ORF which may be involved in the phase variability. Genes within lic1 and lic2 are directly involved in the expression of phase-variable epitopes, but the role of genes within lic3 is at a more complex level.
Asunto(s)
Genes Bacterianos/genética , Haemophilus influenzae/genética , Lipopolisacáridos/genética , Secuencia de Aminoácidos , Anticuerpos Monoclonales/inmunología , Secuencia de Bases , Haemophilus influenzae/inmunología , Haemophilus influenzae/metabolismo , Técnicas In Vitro , Lipopolisacáridos/biosíntesis , Lipopolisacáridos/inmunología , Datos de Secuencia Molecular , Sistemas de Lectura Abierta/genéticaRESUMEN
Proteus mirabilis, a common cause of urinary tract infection, produces a number of different fimbriae, including ambient temperature fimbriae (ATF). These fimbriae are optimally expressed at 23 degrees C and their contribution to urinary tract infection has so far remained unknown. In the present study, a clinical isolate of P. mirabilis and an isogenic allelic replacement mutant unable to express ATF were tested for their ability to cause infection in the ascending urinary tract infection model in mice. The atf mutant colonised the urinary tract as well as the wild-type strain and was also able to outcompete the wild-type strain in a co-challenge experiment. Different non-clinical P. mirabilis isolates showed a reactive AtfA band after Western blot analysis using a polyclonal rabbit AtfA antiserum. These data together suggest that ATF does not play a role in P. mirabilis urinary tract infection.
Asunto(s)
Fimbrias Bacterianas/fisiología , Infecciones por Proteus/microbiología , Proteus mirabilis/patogenicidad , Infecciones Urinarias/microbiología , Alelos , Animales , Anticuerpos Antivirales/inmunología , Femenino , Fimbrias Bacterianas/genética , Ratones , Mutagénesis , Mutación , Fenotipo , Reacción en Cadena de la Polimerasa , Proteus mirabilis/genética , Proteus mirabilis/inmunología , Proteínas Recombinantes/aislamiento & purificaciónRESUMEN
Proteus mirabilis, a common cause of urinary tract infection (UTI), produces a number of different fimbriae including mannose-resistant Proteus-like fimbriae (MR/P). The precise role of different P. mirabilis fimbriae in ascending UTI has not yet been elucidated. In this study, a clinical isolate of P. mirabilis and an isogenic mutant unable to express MR/P were tested using different experimental approaches. They were tested for their ability to cause infection in an ascending co-infection model of UTI and in a haematogenous model in the mouse. In both models, the mutant was less able than the wild-type strain to colonise the lower and upper urinary tracts although infectivity was not abolished. In vitro adherence to uroepithelial cells was also assessed. Significant differences in adherence between both strains were observed at 1 h but not at 15 min post infection. We have also shown that a wild-type strain carries two copies of the mrpA gene. These data reinforce the importance of MR/P fimbriae in P. mirabilis UTI although other virulence factors may be necessary for efficient colonisation and development of infection.
Asunto(s)
Fimbrias Bacterianas/fisiología , Infecciones por Proteus/microbiología , Proteus mirabilis/patogenicidad , Infecciones Urinarias/microbiología , Animales , Adhesión Bacteriana , Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/genética , Proteínas Bacterianas/aislamiento & purificación , Clonación Molecular , Modelos Animales de Enfermedad , Fimbrias Bacterianas/genética , Expresión Génica , Genes Bacterianos/genética , Ratones , Mutación/genética , Fenotipo , Reacción en Cadena de la Polimerasa , Proteus mirabilis/genética , Proteus mirabilis/inmunología , Células Tumorales Cultivadas , VirulenciaRESUMEN
Genetic tools for studying streptococci are much less sophisticated than those that are available for many other bacterial genera. In this paper, we describe the development of a transposon mutagenesis system that we have used to mutate two important veterinary streptococci, Streptococcus equi and Streptococcus suis. The system uses a temperature-sensitive suicide vector to deliver Tn917 via electroporation, transposing Tn917 into the chromosomal DNA of the two streptococci. The transposon insertions can be rescued from the streptococcal chromosomes by plasmid rescue and selection in E. coli, with subsequent insertion site analysis by DNA sequencing. Transposition appeared to have occurred in an essentially random fashion when chromosomal DNA of S. suis and S. equi mutants was analysed by Southern blotting. However, when analysis of 60 S. equi mutants was carried out using the S. equi genome sequence database, 60% of transposon insertions had occurred within a 15 kb region of the genome whereas the other insertions appeared to have occurred essentially randomly. This finding suggests that Southern blot analysis for assessing the randomness of transposon libraries may need to be interpreted with caution. However, this observation notwithstanding, the Tn917 based system described in this paper will facilitate the study of S. suis and S. equi.
Asunto(s)
Elementos Transponibles de ADN/genética , Streptococcus equi/genética , Streptococcus suis/genética , Animales , Southern Blotting/veterinaria , ADN Bacteriano/química , ADN Bacteriano/genética , Electroporación , Vectores Genéticos/química , Vectores Genéticos/genética , Caballos , Mutagénesis Insercional/métodos , Plásmidos , Análisis de Secuencia de ADN , Streptococcus equi/química , Streptococcus suis/química , PorcinosRESUMEN
The galE gene of Streptomyces lividans was used to probe a cosmid library harbouring Brucella melitensis 16M DNA and the nucleotide sequence of a 2.5 kb ClaI fragment which hybridised was determined. An open reading frame encoding a predicted polypeptide with significant homology to UDP-galactose-4-epimerases of Brucella arbortus strain 2308 and other bacterial species was identified. DNA sequences flanking the B. melitensis galE gene shared no identity with other gal genes and, as for B. abortus, were located adjacent to a mazG homologue. A plasmid which encoded the B. melitensis galE open reading frame complemented a galE mutation in Salmonella typhimurium LB5010, as shown by the restoration of smooth lipopolysaccharide (LPS) biosynthesis, sensitivity to phage P22 infection and restoration of UDP-galactose-4-epimerase activity. The galE gene on the B. melitensis 16M chromosome was disrupted by insertional inactivation and these mutants lacked UDP-galactose-4-epimerase activity but no discernible differences in LPS structure between parent and the mutants were observed. One B. melitensis 16M galE mutant, Bm92, was assessed for virulence in CD-1 and BALB/c mice and displayed similar kinetics of invasion and persistence in tissues compared with the parent bacterial strain. CD-1 mice immunised with B. melitensis 16M galE were protected against B. melitensis 16M challenge.
Asunto(s)
Brucella melitensis/genética , Genes Bacterianos/inmunología , UDPglucosa 4-Epimerasa/genética , Secuencia de Aminoácidos , Animales , Bacteriófago P22 , Southern Blotting , Brucella melitensis/enzimología , Brucella melitensis/inmunología , Brucelosis/inmunología , Brucelosis/microbiología , Brucelosis/veterinaria , Clonación Molecular , Recuento de Colonia Microbiana , Cartilla de ADN/química , ADN Bacteriano/química , Femenino , Lipopolisacáridos/análisis , Ratones , Ratones Endogámicos BALB C , Ratones Mutantes , Datos de Secuencia Molecular , Mutagénesis Insercional , Reacción en Cadena de la Polimerasa , Distribución Aleatoria , Alineación de Secuencia , Análisis de Secuencia de ADN , Bazo/microbiología , UDPglucosa 4-Epimerasa/análisis , UDPglucosa 4-Epimerasa/químicaRESUMEN
The structure of the saccharide part of the lipopolysaccharide from Haemophilus influenzae strain AH1-3 (lic3+) has been investigated. The saccharide was obtained from the lipopolysaccharide by mild acid hydrolysis followed by high-performance anion-exchange chromatography, and isolated fractions were studied by methylation analysis, NMR spectroscopy, and FAB mass spectrometry. The major saccharide is a heptasaccharide with the following structure, [formula: see text] in which Kdo is 3-deoxy-D-manno-oct-2-ulosonic acid and PEA is 2-aminoethyl phosphate. Hep is identified as L-glycero-D-manno-heptose. The absolute configuration of the phosphorylated heptose is tentative only.
Asunto(s)
Haemophilus influenzae/química , Lipopolisacáridos/química , Oligosacáridos/química , Secuencia de Carbohidratos , Haemophilus influenzae/genética , Haemophilus influenzae/ultraestructura , Heptosas/análisis , Espectroscopía de Resonancia Magnética , Metilación , Datos de Secuencia Molecular , Mutación , Espectrometría de Masa Bombardeada por Átomos VelocesRESUMEN
Salmonella infections are a serious medical and veterinary problem world-wide and cause concern in the food industry. Vaccination is an effective tool for the prevention of Salmonella infections. Host resistance to Salmonella relies initially on the production of inflammatory cytokines leading to the infiltration of activated inflammatory cells in the tissues. Thereafter T- and B-cell dependent specific immunity develops allowing the clearance of Salmonella microorganisms from the tissues and the establishment of long-lasting acquired immunity to re-infection. The increased resistance that develops after primary infection/ vaccination requires T-cells cytokines such as IFNgamma TNFalpha and IL12 in addition to opsonising antibody. However for reasons that are not fully understood seroconversion and/or the presence of detectable T-cell memory do not always correlate with the development of acquired resistance to infection.Whole-cell killed vaccines and subunit vaccines are used in the prevention of Salmonella infection in animals and in humans with variable results. A number of early live Salmonella vaccines derived empirically by chemical or u.v. mutagenesis proved to be immunogenic and protective and are still in use despite the need for repeated parenteral administration. Recent progress in the knowledge of the genetics of Salmonella virulence and modern recombinant DNA technology offers the possibility to introduce multiple defined attenuating and irreversible mutations into the bacterial genome. This has recently allowed the development of Salmonella strains devoid of significant side effects but still capable of inducing solid immunity after single oral administration. Live attenuated Salmonella vaccines have been used for the expression of heterologous antigens/proteins that can be successfully delivered to the immune system. Furthermore Salmonella can transfer plasmids encoding foreign antigens under the control of eukaryotic promoters (DNA vaccines) to antigen-presenting cells resulting in targeted delivery of DNA vaccines to these cells. Despite the great recent advances in the development of Salmonella vaccines a large proportion of the work has been conducted in laboratory rodents and more research in other animal species is required.
Asunto(s)
Vacunas Bacterianas , Salmonelosis Animal/prevención & control , Salmonella/inmunología , Vacunación/veterinaria , Animales , Anticuerpos Antibacterianos/biosíntesis , Proteínas Bacterianas/genética , Vacunas Bacterianas/inmunología , Citocinas/inmunología , Microbiología de Alimentos , Inmunidad Activa , Salmonella/genética , Salmonelosis Animal/inmunología , Vacunas Atenuadas/inmunologíaRESUMEN
The global epidemic of multidrug-resistant Salmonella Typhimurium DT104 provides an important example, both in terms of the agent and its resistance, of a widely disseminated zoonotic pathogen. Here, with an unprecedented national collection of isolates collected contemporaneously from humans and animals and including a sample of internationally derived isolates, we have used whole-genome sequencing to dissect the phylogenetic associations of the bacterium and its antimicrobial resistance genes through the course of an epidemic. Contrary to current tenets supporting a single homogeneous epidemic, we demonstrate that the bacterium and its resistance genes were largely maintained within animal and human populations separately and that there was limited transmission, in either direction. We also show considerable variation in the resistance profiles, in contrast to the largely stable bacterial core genome, which emphasizes the critical importance of integrated genotypic data sets in understanding the ecology of bacterial zoonoses and antimicrobial resistance.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Interacciones Huésped-Patógeno , Salmonelosis Animal/microbiología , Infecciones por Salmonella/microbiología , Salmonella typhimurium/clasificación , Zoonosis/microbiología , Animales , Epidemias , Genoma Bacteriano , Humanos , Datos de Secuencia Molecular , Filogenia , Infecciones por Salmonella/epidemiología , Salmonelosis Animal/epidemiología , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genéticaAsunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae/clasificación , Actinobacillus pleuropneumoniae/aislamiento & purificación , Serogrupo , Enfermedades de los Porcinos/microbiología , Infecciones por Actinobacillus/epidemiología , Infecciones por Actinobacillus/microbiología , Animales , Inglaterra/epidemiología , Porcinos , Enfermedades de los Porcinos/epidemiología , Gales/epidemiologíaRESUMEN
The F(0)F(1) ATPase plays a central role in both the generation of ATP and the utilisation of ATP for cellular processes such as rotation of bacterial flagella. We have deleted the entire operon encoding the F(0)F(1) ATPase, as well as genes encoding individual F(0) or F(1) subunits, in Salmonella enteric serovar Typhimurium. These mutants were attenuated for virulence, as assessed by bacterial counts in the livers and spleens of intravenously infected mice. The attenuated in vivo growth of the entire atp operon mutant was complemented by the insertion of the atp operon into the malXY pseudogene region. Following clearance of the attenuated mutants from the organs, mice were protected against challenge with the virulent wild type parent strain. We have shown that the F(0)F(1) ATPase is important for bacterial growth in vivo and that atp mutants are effective live attenuated vaccines against Salmonella infection.
Asunto(s)
ATPasas de Translocación de Protón Bacterianas/genética , Eliminación de Gen , Vacunas contra la Salmonella/genética , Vacunas contra la Salmonella/inmunología , Salmonella typhimurium/enzimología , Salmonella typhimurium/patogenicidad , Animales , Recuento de Colonia Microbiana , Femenino , Genes Bacterianos , Prueba de Complementación Genética , Hígado/microbiología , Ratones , Ratones Endogámicos BALB C , Operón , Salmonelosis Animal/microbiología , Salmonella typhimurium/genética , Salmonella typhimurium/inmunología , Bazo/microbiología , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología , VirulenciaAsunto(s)
Bordetella pertussis/genética , Bordetella pertussis/patogenicidad , Vacuna contra la Tos Ferina/uso terapéutico , Tos Ferina/prevención & control , Animales , ADN Bacteriano/análisis , Modelos Animales de Enfermedad , Humanos , Hibridación de Ácido Nucleico , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , ARN Bacteriano/análisis , ConejosRESUMEN
The enzyme phosphoglucomutase (Pgm) catalyses the interconversion of glucose 1-phosphate and glucose 6-phosphate and contributes to glycolysis and the generation of sugar nucleotides for biosynthesis. To assess the role of this enzyme in the biology of the pathogen Salmonella enterica serovar Typhimurium we have characterized a pgm deletion mutant in strain SL1344. Compared to SL1344, SL1344 pgm had impaired growth in vitro, was deficient in the ability to utilize galactose as a carbon source and displayed reduced O-antigen polymer length. The mutant was also more susceptible to antimicrobial peptides and showed decreased fitness in the mouse typhoid model. The in vivo phenotype of SL1344 pgm indicated a role for pgm in the early stages of infection, most likely through deficient O-antigen production. Although pgm mutants in other pathogens have potential as live attenuated vaccine strains, SL1344 pgm was not sufficiently attenuated for such use.
Asunto(s)
Péptidos Catiónicos Antimicrobianos/farmacología , Farmacorresistencia Bacteriana , Antígenos O/biosíntesis , Fosfoglucomutasa/metabolismo , Salmonella typhimurium/enzimología , Animales , Carbono/metabolismo , Femenino , Galactosa/metabolismo , Eliminación de Gen , Hígado/microbiología , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana , Fosfoglucomutasa/genética , Salmonelosis Animal/microbiología , Salmonella typhimurium/genética , Salmonella typhimurium/crecimiento & desarrollo , Bazo/microbiología , VirulenciaRESUMEN
The Gram-negative Tol-Pal system of envelope proteins plays a key role in maintaining outer membrane integrity and contributes to the virulence of several pathogens. We have investigated the role of one of these proteins, TolA, in the biology of Salmonella enterica serovar Typhimurium. Deletion of tolA rendered strain SL1344 more susceptible to killing by bile and human serum. In addition the mutant had impaired membrane integrity and displayed alterations in LPS production. The tolA mutant was highly attenuated in mouse infections via the oral and intravenous routes. Importantly, each phenotype displayed by the mutant was complemented by provision of tolA in trans. The tolA gene therefore contributes to virulence, membrane integrity, LPS production and bile and serum resistance in S. enterica serovar Typhimurium SL1344. Finally, immunization with the tolA mutant provided significant protection against subsequent challenge with wild-type SL1344. The Tol-Pal system is therefore a potential target in the development of novel attenuated live vaccines against Salmonella and other Gram-negative pathogens.